Skip to main content
Top
Published in: BMC Gastroenterology 1/2024

Open Access 01-12-2024 | Fatty Liver | Research

Dietary inflammatory index in relation to the progression of hepatic steatosis and liver fibrosis: evaluation by elastography/Fibroscan

Authors: Mahsa Miryan, Sameeah Abdulrahman Rashid, Jamshid Gholizadeh Navashenaq, Davood Soleimani, Mohsen Nematy, Jalal Moludi

Published in: BMC Gastroenterology | Issue 1/2024

Login to get access

Abstract

One of the proposed mechanisms by which nutrition influences the progression of hepatic steatosis to fibrosis is inflammation. The study investigated how the inflammatory potential of the diet affects the risk of liver damage in patients with nonalcoholic fatty liver disease (NAFLD), a condition where fat accumulates in the liver. This cross-sectional study included 170 outpatients with newly diagnosed NAFLD. This study used a device called Fibroscan® to measure the degree of liver fibrosis, which is the scarring of the liver tissue due to chronic inflammation. The study also used a tool called the Dietary Inflammatory Index (DII) to measure the inflammatory potential of the diet based on the intake of different foods and nutrients. In the findings of the study, patients with more severe fat accumulation in the liver (hepatic steatosis) had higher DII scores, meaning they had more inflammatory diets. The study also found that higher DII scores were associated with higher weight and body mass index (BMI). One standard deviation (SD) increase in DII scores was associated with a 0.29 kilopascal (95% CI: 0.10–0.44; P-value 0.001) increase in the mean liver stiffness, an indicator of liver fibrosis. The study concluded that patients with higher DII scores had a higher risk of developing liver fibrosis than those with lower DII scores, even after adjusting for confounding factors (odds ratio: 5.89; P-value: 0.001). The study suggested that eating less inflammatory foods may help prevent or slow down the progression of hepatic steatosis and liver in patients with NAFLD.
Literature
1.
go back to reference Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–84.CrossRefPubMed Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–84.CrossRefPubMed
2.
go back to reference Singh S, Allen AM, Wang Z, Prokop LJ, Murad MH, Loomba R. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol. 2015;13(4):643–54. e1-9; quiz e39-40.CrossRefPubMed Singh S, Allen AM, Wang Z, Prokop LJ, Murad MH, Loomba R. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol. 2015;13(4):643–54. e1-9; quiz e39-40.CrossRefPubMed
4.
go back to reference Giugliano D, Ceriello A, Esposito K. The effects of diet on inflammation: emphasis on the metabolic syndrome. J Am Coll Cardiol. 2006;48(4):677–85.CrossRefPubMed Giugliano D, Ceriello A, Esposito K. The effects of diet on inflammation: emphasis on the metabolic syndrome. J Am Coll Cardiol. 2006;48(4):677–85.CrossRefPubMed
5.
6.
go back to reference Hu FB. Dietary pattern analysis: a new direction in nutritional epidemiology. Curr Opin Lipidol. 2002;13(1):3–9.CrossRefPubMed Hu FB. Dietary pattern analysis: a new direction in nutritional epidemiology. Curr Opin Lipidol. 2002;13(1):3–9.CrossRefPubMed
7.
go back to reference Shivappa N, Steck SE, Hurley TG, Hussey JR, Hébert JR. Designing and developing a literature-derived, population-based dietary inflammatory index. Public Health Nutr. 2014;17(8):1689–96.CrossRefPubMed Shivappa N, Steck SE, Hurley TG, Hussey JR, Hébert JR. Designing and developing a literature-derived, population-based dietary inflammatory index. Public Health Nutr. 2014;17(8):1689–96.CrossRefPubMed
8.
go back to reference Shivappa N, Godos J, Hébert JR, Wirth MD, Piuri G, Speciani AF et al. Dietary Inflammatory Index and Cardiovascular Risk and Mortality-A Meta-Analysis. Nutrients. 2018;10(2). Shivappa N, Godos J, Hébert JR, Wirth MD, Piuri G, Speciani AF et al. Dietary Inflammatory Index and Cardiovascular Risk and Mortality-A Meta-Analysis. Nutrients. 2018;10(2).
9.
go back to reference Moludi J, Qaisar SA, Alizadeh M, Vayghan HJ, Naemi M, Rahimi A, Mousavi R. The relationship between Dietary Inflammatory Index and disease severity and inflammatory status: A case–control study of COVID-19 patients. Br. J. Nutr. 2022;127(5):773–81. Moludi J, Qaisar SA, Alizadeh M, Vayghan HJ, Naemi M, Rahimi A, Mousavi R. The relationship between Dietary Inflammatory Index and disease severity and inflammatory status: A case–control study of COVID-19 patients. Br. J. Nutr. 2022;127(5):773–81.
10.
go back to reference Canto-Osorio F, Denova-Gutierrez E, Sánchez-Romero LM, Salmerón J, Barrientos-Gutierrez T. Dietary inflammatory index and metabolic syndrome in Mexican adult population. Am J Clin Nutr. 2020;112(2):373–80.CrossRefPubMed Canto-Osorio F, Denova-Gutierrez E, Sánchez-Romero LM, Salmerón J, Barrientos-Gutierrez T. Dietary inflammatory index and metabolic syndrome in Mexican adult population. Am J Clin Nutr. 2020;112(2):373–80.CrossRefPubMed
11.
go back to reference King DE, Xiang J. The Dietary Inflammatory Index is Associated with Diabetes Severity. J Am Board Family Medicine: JABFM. 2019;32(6):801–6.CrossRefPubMed King DE, Xiang J. The Dietary Inflammatory Index is Associated with Diabetes Severity. J Am Board Family Medicine: JABFM. 2019;32(6):801–6.CrossRefPubMed
12.
go back to reference Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ronchi G, et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut. 2007;56(7):968–73.CrossRefPubMedPubMedCentral Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ronchi G, et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut. 2007;56(7):968–73.CrossRefPubMedPubMedCentral
13.
go back to reference Boursier J, Zarski JP, de Ledinghen V, Rousselet MC, Sturm N, Lebail B, et al. Determination of reliability criteria for liver stiffness evaluation by transient elastography. Hepatology. 2013;57(3):1182–91.CrossRefPubMed Boursier J, Zarski JP, de Ledinghen V, Rousselet MC, Sturm N, Lebail B, et al. Determination of reliability criteria for liver stiffness evaluation by transient elastography. Hepatology. 2013;57(3):1182–91.CrossRefPubMed
14.
go back to reference Abenavoli L, Beaugrand M. Transient elastography in non-alcoholic fatty liver disease. Ann Hepatol. 2012;11(2):172–8.CrossRefPubMed Abenavoli L, Beaugrand M. Transient elastography in non-alcoholic fatty liver disease. Ann Hepatol. 2012;11(2):172–8.CrossRefPubMed
15.
go back to reference Sasso M, Beaugrand M, De Ledinghen V, Douvin C, Marcellin P, Poupon R, et al. Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol. 2010;36(11):1825–35.CrossRefPubMed Sasso M, Beaugrand M, De Ledinghen V, Douvin C, Marcellin P, Poupon R, et al. Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol. 2010;36(11):1825–35.CrossRefPubMed
16.
go back to reference Pourhoseingholi MA, Vahedi M, Rahimzadeh M. Sample size calculation in medical studies. Gastroenterol Hepatol bed Bench. 2013;6(1):14–7.PubMedPubMedCentral Pourhoseingholi MA, Vahedi M, Rahimzadeh M. Sample size calculation in medical studies. Gastroenterol Hepatol bed Bench. 2013;6(1):14–7.PubMedPubMedCentral
17.
go back to reference Soleimani D, Ranjbar G, Rezvani R, Goshayeshi L, Razmpour F, Nematy M. Dietary patterns in relation to hepatic fibrosis among patients with nonalcoholic fatty liver disease. Diabetes Metabolic Syndrome Obesity: Targets Therapy. 2019;12:315–24.CrossRefPubMed Soleimani D, Ranjbar G, Rezvani R, Goshayeshi L, Razmpour F, Nematy M. Dietary patterns in relation to hepatic fibrosis among patients with nonalcoholic fatty liver disease. Diabetes Metabolic Syndrome Obesity: Targets Therapy. 2019;12:315–24.CrossRefPubMed
18.
go back to reference Soltanieh S, Salavatizadeh M, Poustchi H, Yari Z, Mansour A, Khamseh ME et al. The association of dietary inflammatory index (DII) and central obesity with non-alcoholic fatty liver disease (NAFLD) in people with diabetes (T2DM). Heliyon. 2023;9(3). Soltanieh S, Salavatizadeh M, Poustchi H, Yari Z, Mansour A, Khamseh ME et al. The association of dietary inflammatory index (DII) and central obesity with non-alcoholic fatty liver disease (NAFLD) in people with diabetes (T2DM). Heliyon. 2023;9(3).
19.
go back to reference Valibeygi A, Davoodi A, Dehghan A, Vahid F, Hébert JR, Farjam M, et al. Dietary inflammatory index (DII) is correlated with the incidence of non-alcoholic fatty liver disease (NAFLD): Fasa PERSIAN cohort study. BMC Nutr. 2023;9(1):84.CrossRefPubMedPubMedCentral Valibeygi A, Davoodi A, Dehghan A, Vahid F, Hébert JR, Farjam M, et al. Dietary inflammatory index (DII) is correlated with the incidence of non-alcoholic fatty liver disease (NAFLD): Fasa PERSIAN cohort study. BMC Nutr. 2023;9(1):84.CrossRefPubMedPubMedCentral
20.
go back to reference Farhadnejad H, Tehrani AN, Jahromi MK, Teymoori F, Mokhtari E, Salehi-Sahlabadi A, et al. The association between dietary inflammation scores and non-alcoholic fatty liver diseases in Iranian adults. BMC Gastroenterol. 2022;22(1):1–9.CrossRef Farhadnejad H, Tehrani AN, Jahromi MK, Teymoori F, Mokhtari E, Salehi-Sahlabadi A, et al. The association between dietary inflammation scores and non-alcoholic fatty liver diseases in Iranian adults. BMC Gastroenterol. 2022;22(1):1–9.CrossRef
21.
go back to reference Vahid F, Shivappa N, Hekmatdoost A, Hebert JR, Poustchi H, Shamsipour A, et al. Association of pro-inflammatory dietary intake and non-alcoholic fatty liver disease: findings from Iranian case-control study. International Journal for Vitamin and Nutrition Research; 2019. Vahid F, Shivappa N, Hekmatdoost A, Hebert JR, Poustchi H, Shamsipour A, et al. Association of pro-inflammatory dietary intake and non-alcoholic fatty liver disease: findings from Iranian case-control study. International Journal for Vitamin and Nutrition Research; 2019.
22.
go back to reference Cantero I, Abete I, Babio N, Arós F, Corella D, Estruch R, et al. Dietary inflammatory index and liver status in subjects with different adiposity levels within the PREDIMED trial. Clin Nutr. 2018;37(5):1736–43.CrossRefPubMed Cantero I, Abete I, Babio N, Arós F, Corella D, Estruch R, et al. Dietary inflammatory index and liver status in subjects with different adiposity levels within the PREDIMED trial. Clin Nutr. 2018;37(5):1736–43.CrossRefPubMed
23.
go back to reference Ramírez-Vélez R, García‐Hermoso A, Izquierdo M, Correa‐Rodríguez M. The Dietary Inflammatory Index and hepatic health in the US adult population. J Hum Nutr Dietetics. 2022;35(5):968–79.CrossRef Ramírez-Vélez R, García‐Hermoso A, Izquierdo M, Correa‐Rodríguez M. The Dietary Inflammatory Index and hepatic health in the US adult population. J Hum Nutr Dietetics. 2022;35(5):968–79.CrossRef
24.
go back to reference Doustmohammadian A, Amirkalali B, Esfandyari S, Motamed N, Maadi M, Shivappa N et al. The association between dietary inflammatory index (DII) scores and c-reactive protein (CRP) and non-alcoholic fatty liver disease (NAFLD) in a general population cohort. Clin Nutr ESPEN. 2024. Doustmohammadian A, Amirkalali B, Esfandyari S, Motamed N, Maadi M, Shivappa N et al. The association between dietary inflammatory index (DII) scores and c-reactive protein (CRP) and non-alcoholic fatty liver disease (NAFLD) in a general population cohort. Clin Nutr ESPEN. 2024.
25.
go back to reference Zhao Q, Deng Y, Gong R, Chen T, Yang L. Association between dietary inflammatory index and risk of fatty liver disease: a systematic review and meta-analysis. Digestive and Liver Disease; 2023. Zhao Q, Deng Y, Gong R, Chen T, Yang L. Association between dietary inflammatory index and risk of fatty liver disease: a systematic review and meta-analysis. Digestive and Liver Disease; 2023.
26.
go back to reference Grimble RF. Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metabolic Care. 2002;5(5):551–9.CrossRef Grimble RF. Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metabolic Care. 2002;5(5):551–9.CrossRef
27.
go back to reference Templeman NM, Skovsø S, Page MM, Lim GE, Johnson JD. A causal role for hyperinsulinemia in obesity. J Endocrinol. 2017;232(3):R173–83.CrossRefPubMed Templeman NM, Skovsø S, Page MM, Lim GE, Johnson JD. A causal role for hyperinsulinemia in obesity. J Endocrinol. 2017;232(3):R173–83.CrossRefPubMed
28.
go back to reference Ameer F, Scandiuzzi L, Hasnain S, Kalbacher H, Zaidi N. De novo lipogenesis in health and disease. Metab Clin Exp. 2014;63(7):895–902.CrossRefPubMed Ameer F, Scandiuzzi L, Hasnain S, Kalbacher H, Zaidi N. De novo lipogenesis in health and disease. Metab Clin Exp. 2014;63(7):895–902.CrossRefPubMed
29.
go back to reference Zhang Z, Wang L, Lin Z, Yan W, Chen J, Zhang X, et al. Dietary inflammatory index and risk of non-alcoholic fatty liver disease and advanced hepatic fibrosis in US adults. Front Nutr. 2023;10:1102660.CrossRefPubMedPubMedCentral Zhang Z, Wang L, Lin Z, Yan W, Chen J, Zhang X, et al. Dietary inflammatory index and risk of non-alcoholic fatty liver disease and advanced hepatic fibrosis in US adults. Front Nutr. 2023;10:1102660.CrossRefPubMedPubMedCentral
30.
go back to reference Li R, Li M, Bidulescu A, Fly AD, Luo J. Diets with higher anti-inflammatory potential associated with lower risk of development of nonalcoholic fatty liver disease and early-stage of fibrosis among US adults. Dig Dis Sci. 2023;68(10):4009–21.CrossRefPubMed Li R, Li M, Bidulescu A, Fly AD, Luo J. Diets with higher anti-inflammatory potential associated with lower risk of development of nonalcoholic fatty liver disease and early-stage of fibrosis among US adults. Dig Dis Sci. 2023;68(10):4009–21.CrossRefPubMed
31.
go back to reference Miryan M, Darbandi M, Moradi M, Najafi F, Soleimani D, Pasdar Y. Relationship between the Mediterranean diet and risk of hepatic fibrosis in patients with non-alcoholic fatty liver disease: a cross-sectional analysis of the RaNCD cohort. Front Nutr. 2023;10:1062008.CrossRefPubMedPubMedCentral Miryan M, Darbandi M, Moradi M, Najafi F, Soleimani D, Pasdar Y. Relationship between the Mediterranean diet and risk of hepatic fibrosis in patients with non-alcoholic fatty liver disease: a cross-sectional analysis of the RaNCD cohort. Front Nutr. 2023;10:1062008.CrossRefPubMedPubMedCentral
32.
go back to reference Kontogianni MD, Tileli N, Margariti A, Georgoulis M, Deutsch M, Tiniakos D, et al. Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease. Clin Nutr. 2014;33(4):678–83.CrossRefPubMed Kontogianni MD, Tileli N, Margariti A, Georgoulis M, Deutsch M, Tiniakos D, et al. Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease. Clin Nutr. 2014;33(4):678–83.CrossRefPubMed
33.
go back to reference Adriano LS, de Carvalho Sampaio HA, Arruda SPM, de Melo Portela CL, de Melo MLP, Carioca AAF, et al. Healthy dietary pattern is inversely associated with non-alcoholic fatty liver disease in elderly. Br J Nutr. 2016;115(12):2189–95.CrossRefPubMed Adriano LS, de Carvalho Sampaio HA, Arruda SPM, de Melo Portela CL, de Melo MLP, Carioca AAF, et al. Healthy dietary pattern is inversely associated with non-alcoholic fatty liver disease in elderly. Br J Nutr. 2016;115(12):2189–95.CrossRefPubMed
34.
go back to reference Tandorost A, Kheirouri S, Moludi J, Seyedmardani S. Association of Dietary Inflammatory Index (DII) with disease activity and inflammatory cytokines in the patients with rheumatoid arthritis. Int. J. Clin. Pract. 2021;75(11):e14792. Tandorost A, Kheirouri S, Moludi J, Seyedmardani S. Association of Dietary Inflammatory Index (DII) with disease activity and inflammatory cytokines in the patients with rheumatoid arthritis. Int. J. Clin. Pract. 2021;75(11):e14792.
Metadata
Title
Dietary inflammatory index in relation to the progression of hepatic steatosis and liver fibrosis: evaluation by elastography/Fibroscan
Authors
Mahsa Miryan
Sameeah Abdulrahman Rashid
Jamshid Gholizadeh Navashenaq
Davood Soleimani
Mohsen Nematy
Jalal Moludi
Publication date
01-12-2024
Publisher
BioMed Central
Keyword
Fatty Liver
Published in
BMC Gastroenterology / Issue 1/2024
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-024-03209-8

Other articles of this Issue 1/2024

BMC Gastroenterology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.